Diet-induced changes in membrane gangliosides in rat intestinal mucosa, plasma and brain

Journal of Pediatric Gastroenterology and Nutrition

Volumn 40, Issue 4, 2005, Pages 487-495

  Park, Eek Joong ^a   Suh, Miyoung ^a   Ramanujam, Kal ^b   Steiner, Kurt ^b   Begg, David ^a   Clandinin, M Thomas ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PFIZER INC   (United States)

Author keywords

Brain; Diet; Ganglioside; Intestine; Plasma; Rat

Indexed keywords

CHOLESTEROL; GANGLIOSIDE; GANGLIOSIDE GD3; GANGLIOSIDE GM3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CELL MEMBRANE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; LIPID DIET; MALE; NEWBORN; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN CHEMISTRY; CHOLESTEROL; ENTEROCYTES; FLUORESCENT ANTIBODY TECHNIQUE; G(M3) GANGLIOSIDE; GANGLIOSIDES; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MEMBRANE LIPIDS; MICROSCOPY, CONFOCAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 16844364569     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MPG.0000157199.25923.64     Document Type: Article

References (51)

1. Byrne MC, Ledeen RW, Roisen FJ, Yorke G, Sclafani JR, Ganglioside-induced neuritogenesis: verification that gangliosides are the active agents, and comparison of molecular species. J Neurochem 1983;41:1214-22.
2. De Maria R, Lenti L, Malisan F, et al. Requirement for GD3 ganglioside in. Science 1997;277:1652-5.
3. Ledeen RW. Neurobiology of Glycoconjugates. New York: Plenum Press; 1989.
4. Ortaldo JR, Mason AT, Longo DL, et al. T cell activation via the disialoganglioside GD3: analysis of signal transduction. J Leukoc Biol 1996;60:533-9.
5. Vanier MT, Holm M, Ohman R, Svennerholm L. Developmental profiles of gangliosides in human and rat brain. J Neurochem 1971;18:581-92.
6. Bouhours D, Bouhours JF. Developmental changes of hematoside of rat small intestine. Postnatal hydroxylation of fatty acids and sialic acid. J Biol Chem 1983;258:299-304.
7. Kolter T, Sandhoff K. Glycosphingolipid degradation and animal models of GM2-gangliosidoses. J Inherit Metab Dis 1998;21:548-63.
8. Allende ML, Li J, Darling DS, Worth CA, Young WW Jr. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion. Glycobiology 2000;10:1025-32.
9. Schwarzmann G, Sandhoff K. Metabolism and intracellular transport of glycosphingolipids. Biochemistry 1990;29:10865-71.
10. Iber H, Zacharias C, Sandhoff K. The c-series gangliosides GT3, GT2 and GP1c are formed in rat liver Golgi by the same set of glycosyltransferases that catalyse the biosynthesis of asialo-, a- and b-series gangliosides. Glycobiology 1992;2:137-42.
11. Rolsma MD, Kuhlenschmidt TB, Gelberg HB, Kuhlenschmidt MS. Structure and function of a ganglioside receptor for porcine rotavirus. J Virol 1998;72:9079-91.
12. Laegreid A, Kolsto Otnaess AB. Trace amounts of ganglioside GM1 in human milk inhibit enterotoxins from Vibrio cholerae and Escherichia coli. Life Sci 1987;40:55-62.
13. Weite K, Miller G, Chapman PB, et al. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J Immunol 1987;139:1763-71.
14. Takamizawa K, Iwamori M, Mutai M, Nagai Y. Selective changes in gangliosides of human milk during lactation: a molecular indicator for the period of lactation. Biochim Biophys Acta 1986;879:73-7.
15. Krajnc D, Wemlinger TA, Neff NH, Hadjiconstantinou M. Neonatal hypoxia: early neurotransmitter responses and the consequences of treatment with GM1 ganglioside. J Pharmacol Exp Ther 1994;271:1299-305.
16. Mohand-Said S, Weber M, Hicks D, Dreyfus H, Sahel JA. Intravitreal injection of ganglioside GM1 after ischemia reduces retinal damage in rats. Stroke 1997;28:617-21.
17. Lazzaro A, Seren MS, Koga T, et al. GM1 reduces infarct volume after focal cerebral ischemia. Exp Neurol 1994;125:278-85.
18. Slotte JP. Sphingomyelin-cholesterol interactions in biological and model membranes. Chem Phys Lipids 1999;102:13-27.
19. Chen H, Born E, Mathur SN, Johlin FC Jr, Field FJ. Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity. Biochem J 1992;286(Pt 3):771-7.
20. Maekawa S, Sato C, Kitajima K, et al. Cholesterol-dependent localization of NAP-22 on a neuronal membrane microdomain (raft). J Biol Chem 1999;274:21369-74.
21. Clandinin MT, Yamashiro S. Effects of methionine supplementation on the incidence of dietary fat induced myocardial lesions in the rat. J Nutr 1980;110:1197-203.
22. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal. J Biol Chem 1957;226:497-509.
23. Williams MA, McCluer RH. The use of Sep-Pak C18 cartridges during the isolation of gangliosides. J Neurochem 1980;35:266-9.
24. Suzuki K. A simple and accurate micromethod for quantitative determination of ganglioside patterns. Life Sci 1964;3:1227-33.
25. Svennerholm L. Quantitative estimation of sialic acids: A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 1957;24:604-11.
26. Sonnino S, Ghidoni R, Chigorno V, Masserini M, Tettamanti G. Recognition by two-dimensional thin-layer chromatography and densitometric quantification of alkali-labile gangliosides from the brain of different animals. Anal Biochem 1983;128:104-14.
27. Holgersson J, Stromberg N, Breimer ME. Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelial tissue and the ABO, Le and Se phenotypes of the donors. Biochimie 1988;70:1565-74.
28. Lencer WI, Moe S, Rufo PA, Madara JL. Transcytosis of cholera toxin subunits across model human intestinal epithelia. Proc Natl Acad Sci U S A 1995;92:10094-8.
29. Perkkio M, Savilahti E. Time of appearance of immunoglobulin-containing cells in the mucosa of the neonatal intestine. Pediatr Res 1980;14:953-5.
30. Carlson SE. N-acetylneuraminic acid concentrations in human milk oligosaccharides and glycoproteins during lactation. Am J Clin Nutr 1985;41:720-6.
31. Schmelz EM, Sullards MC, Dillehay DL, Merrill AH Jr. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J Nutr 2000;130:522-7.
32. Senn HJ, Orth M, Fitzke E, Wieland H, Gerok W. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur J Biochem 1989;181:657-62.
33. Karlsson I, Svennerholm L. Biochemical development of rat forebrains in severe protein and essential fatty acid deficiencies. J Neurochem 1978;31:657-62.
34. Morgan BL, Winick M. Effects of administration of N-acetylneuraminic acid (NANA) on brain NANA content and behavior. J Nutr 1980;110:416-24.
35. Aydin M, Cengiz S, Agachan B, Yilmaz H, Isbir T. Age-related changes in GM1, GD1a, GT1b components of gangliosides in Wistar albino rats. Cell Biochem Fund 2000;18:41-5.
36. Rietveld A, Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys Acta 1998;1376:467-79.
37. Malewicz B, Kumar VV, Johnson RG, Baumann WJ. Lipids in gap junction assembly and function. Lipids 1990;25:419-27.
38. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998;14:111-36.
39. Parpal S, Karlsson M, Thorn H, Stralfors P. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J Biol Chem 2001;276:9670-8.
40. Samuel BU, Mohandas N, Harrison T, et al. The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection. J Biol Chem 2001;276:29319-29.
41. Kobayashi T, Shimizugawa T, Osakabe T, Watanabe S, Okuyama H. A long-term feeding of sphingolipids affected the levels of plasma cholesterol and hepatic triacylglycerol but not tissue phospholipids and sphingolipids. Nutr Res 1997;17:111-4.
42. Imaizumi K, Tominaga A, Sato M, Sugano M. Effects of dietary sphingolipids on levels of serum and liver lipids in rats. Nutr Res 1992;12:543-8.
43. Bastiaanse EM, Hold KM, Van der LA. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res 1997;33:272-83.
44. Edmond J, Korsak RA, Morrow JW, Torok-Both G, Catlin DH. Dietary cholesterol and the origin of cholesterol in the brain of developing rats. J Nutr 1991;121:1323-30.
45. Clandinin MT, Cheema S, Field CJ, et al. Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 1991;5:2761-9.
46. Incardona JP, Eaton S. Cholesterol in signal transduction. Curr Opin Cell Biol 2000;12:193-203.
47. Parton RG. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem 1994;42:155-66.
48. Wang Y, Yamaguchi K, Wada T, et al. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 2002;277:26252-9.
49. Zha Q, Ruan Y, Hartmann T, Beyreuther K, Zhang D. GM1 ganglioside regulates the proteolysis of amyloid precursor protein. Mol Psychiatry 2004.
50. Pan XL, Izumi T. Variation of the ganglioside compositions of human milk, cow's milk and infant formulas. Early Hum Dev 2000;57:25-31.
51. Sanchez-Diaz A, Ruano MJ, Lorente F, Hueso P. A critical analysis of total sialic acid and sialoglycoconjugate contents of bovine milk-based infant formulas. J Pediatr Gastroenterol Nutr 1997;24:405-10.